Portland Man Sentenced to 11 Years for Crack Conspiracy and Distribution
PORTLAND, ME - November 06, 2015 - United States Attorney Thomas E. Delahanty II announced that Marco Gordon, 34, of Portland was sentenced today to 11 years in prison and five years of supervised release for conspiring to distribute cocaine base, often referred to as crack cocaine, and possession with intent to distribute crack cocaine. He was also ordered to forfeit $4,415. He pleaded guilty to the charges on July 7, 2015.
Court records reveal that between December 2013 and January 2015, Marco Gordon conspired with others, including, Russell Gordon and Robert Joiner, to sell crack cocaine in Portland. Members of the conspiracy would arrange for the acquisition of drugs out of state. Once the drugs were transported to Maine, they were provided to retail distributors, including Marco Gordon, who would sell the drugs in the Portland area, and then return the cash proceeds to Russell Gordon. During the course of the investigation, law enforcement officers conducted controlled purchases of crack cocaine from several members of the conspiracy. Marco Gordon was arrested on January 9, 2015, and found to be in possession of over 180 grams of crack cocaine and over $4,000.
Robert Joiner was previously sentenced to three years in prison. Russell Gordon has entered a guilty plea and awaits sentencing.
This case was investigated by the Southern Maine Gang Task Force, which is comprised of investigators from the Federal Bureau of Investigation; the Portland, South Portland, Biddeford and Lewiston Police Departments; U.S. Immigration and Customs Enforcement’s Homeland Security Investigations; the Bureau of Alcohol, Tobacco, Firearms and Explosives; and the U.S. Drug Enforcement Administration. The Maine Drug Enforcement Agency and the Maine State Police also assisted with the investigation.
The case also results from the ongoing effort of the Organized Crime Drug Enforcement Task Forces (OCDETF), a partnership between federal, state and local law enforcement agencies. The principal mission of the OCDETF program is to identify, disrupt and dismantle the most serious drug trafficking, weapons trafficking and money laundering organizations, and those primarily responsible for the nation’s illegal drug supply.
U.S. Attorney’s Office
District of Maine
This content has been reproduced from its original source.
U.S. FDA Approves Gilead Sciences' (Nasdaq: GILD) Antiviral Veklury (remdesivir) for the Treatment of COVID-19
